Literature DB >> 10480711

Injections given in healthcare settings as a major source of acute hepatitis B in Moldova.

Y J Hutin1, R Harpaz, J Drobeniuc, A Melnic, C Ray, M Favorov, P Iarovoi, C N Shapiro, B A Woodruff.   

Abstract

BACKGROUND: Reported rates of acute hepatitis B are high in many former Soviet Union republics and modes of transmission are not well defined.
METHODS: Two case-control studies were undertaken in Moldova to identify risk factors for acute hepatitis B in people aged 2-15 years (children) and > or =15 years (adults). Serologically confirmed acute hepatitis B cases occurring between 1 January 1994 and 30 August 30 1995, were matched on age, sex, and district of residence to three potential controls who were tested for hepatitis B markers to exclude the immune. Stratified odds ratios (SOR) were calculated using bivariate and multivariate methods.
RESULTS: In multivariate analysis, compared with the 175 controls, the 70 adult cases (mean age 25 years, 66% male) were more likely to report receiving injections in the 6 months before illness during a dental visit (SOR = 21; 95% CI: 3.7-120), a hospital visit (SOR = 35; 95% CI: 7.2-170), or a visit to the polyclinic (SOR = 13; 95% CI: 2.4-74). Among children, receiving injections during a hospital visit (SOR = 5.2; 95% CI: 1.2-23) was the only exposure reported significantly more often by the 19 cases (mean age 8 years, 68% male) compared with the 81 controls.
CONCLUSION: These results, along with reported unsafe injection practices in Moldova, suggest that injections are a major source of hepatitis B virus transmission and highlight the importance of proper infection-control procedures in preventing transmission of blood-borne infections.

Entities:  

Keywords:  Adult; Age Factors; Biology; Case Control Studies; Child; Delivery Of Health Care; Demographic Factors; Developed Countries; Diseases; Eastern Europe; Europe; Health; Health Facilities; Health Services; Hepatitis--determinants; Hepatitis--transmission; Moldova; New Independent States; Population; Population Characteristics; Research Methodology; Research Report; Risk Factors; Studies; Viral Diseases; Youth

Mesh:

Substances:

Year:  1999        PMID: 10480711     DOI: 10.1093/ije/28.4.782

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  11 in total

Review 1.  Use of injections in healthcare settings worldwide, 2000: literature review and regional estimates.

Authors:  Yvan J F Hutin; Anja M Hauri; Gregory L Armstrong
Journal:  BMJ       Date:  2003-11-08

2.  Hepatitis B virus infection among different sex and age groups in Pakistani Punjab.

Authors:  Fawad Khan; Sulaiman Shams; Ihteshamud Din Qureshi; Muhmmad Israr; Hayat Khan; Muhammad Tahir Sarwar; Muhammad Ilyas
Journal:  Virol J       Date:  2011-05-13       Impact factor: 4.099

Review 3.  Enigmatic origin of hepatitis B virus: an ancient travelling companion or a recent encounter?

Authors:  Gianguglielmo Zehender; Erika Ebranati; Elena Gabanelli; Chiara Sorrentino; Alessandra Lo Presti; Elisabetta Tanzi; Massimo Ciccozzi; Massimo Galli
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

4.  Substantial decline in hepatitis B virus infections following vaccine introduction in Tajikistan.

Authors:  Nino Khetsuriani; Faina Tishkova; Shamsidin Jabirov; Kathleen Wannemuehler; Saleem Kamili; Zulfiya Pirova; Liudmila Mosina; Eugene Gavrilin; Pavel Ursu; Jan Drobeniuc
Journal:  Vaccine       Date:  2015-06-10       Impact factor: 3.641

5.  Examining unsafe injection practices associated with auto-disable (AD) syringes: a systematic review.

Authors:  Anokhi Ali Khan; Mehr Munir; Fatima Miraj; Shayan Imran; Danya Arif Siddiqi; Arshad Altaf; Aamir Javed Khan; Subhash Chandir
Journal:  Hum Vaccin Immunother       Date:  2021-05-14       Impact factor: 3.452

6.  Spatial and temporal dynamics of hepatitis B virus D genotype in Europe and the Mediterranean Basin.

Authors:  Gianguglielmo Zehender; Erika Ebranati; Elena Gabanelli; Renata Shkjezi; Alessia Lai; Chiara Sorrentino; Alessandra Lo Presti; Mimoza Basho; Raffaele Bruno; Elisabetta Tanzi; Silvia Bino; Massimo Ciccozzi; Massimo Galli
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

7.  Risk factors of hepatitis B virus infection in Turkey: A population-based, case-control study: Risk Factors for HBV Infection.

Authors:  Ali Ozer; Yusuf Yakupogullari; Ali Beytur; Leyla Beytur; Mehmet Koroglu; Feyza Salman; Fisun Aydogan
Journal:  Hepat Mon       Date:  2011-04       Impact factor: 0.660

8.  Estimating the Burden of Disease from Unsafe Injections in India: A Cost-benefit Assessment of the Auto-disable Syringe in a Country with Low Blood-borne Virus Prevalence.

Authors:  Savanna Reid
Journal:  Indian J Community Med       Date:  2012-04

9.  Risk factors of hepatitis B transmission in northern Palestine: a case - control study.

Authors:  Zaher Nazzal; Inam Sobuh
Journal:  BMC Res Notes       Date:  2014-03-28

10.  Prevalence of hepatitis B, C, and HIV among patients attending a teaching dental hospital. A 7-year retrospective study from the United Arab Emirates.

Authors:  Suhail H Al-Amad
Journal:  Saudi Med J       Date:  2018-05       Impact factor: 1.484

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.